INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03FWFogarty Patrick W0B / 90S90 trades$362K
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 32S32 trades$5.48M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,797 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
1,323 sh
Jan 15, 2026Jan 16, 2026
Page 1450 of 1795
← PrevNext →
traded Jan 15, 2026
+1d
SEC Form 4

Evidence

9
GJ
Gregory Andrew J. Jr.Chief Financial Officer
PNFPPinnacle Financial Partners, Inc.
Grant or award
A—
13.3K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

8
SJ
Scott JacobGENERAL COUNSEL AND CORP. SEC.
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$154K
21.7K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

8
GD
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
BDXBECTON DICKINSON & CO
Open-market sale · 10b5-1 plan
SELL$125K
600 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

8
BS
Blanchard SarahChief Financial Officer
UDMYUdemy, Inc.
Tax withholding
F$56K
10.7K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

8
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
200 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

8
JT
Jarboe Scott T.CAO and Corporate Secretary
BTUPEABODY ENERGY CORP
Open-market sale · 10b5-1 plan
SELL$74K
2,151 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

8
RW
Ruttenberg David W.Director
ACELAccel Entertainment, Inc.
Open-market sale · 10b5-1 plan
SELL$145K
12.5K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

7
FJ
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
NTRANatera, Inc.
Grant or award · 10b5-1 plan
A—
44.7K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

7
DA
D'Amico AndrewDirector
VICRVICOR CORP
Option exercise · 10b5-1 plan
M—
200 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

7
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M—
321 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

6
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$126K
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

6
SC
Sumner CrystalSee Remarks
MQMarqeta, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
5,055 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

6
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$126K
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

5
LL
Larroque Alexander LisaSVP, Corp Affairs and HR
SRESEMPRA
Tax withholding
F$923
10 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

5
SL
Sedgwick Karen LExecutive VP and CFO
SRESEMPRA
Tax withholding
F$568
6 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

5
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise
M—
250 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

5
WZ
Wold Dyan Z.VP, Controller and CAO
SRESEMPRA
Tax withholding
F$487
5 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$18K
459 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

5
WA
Winn Caroline AnnExecutive Vice President
SRESEMPRA
Tax withholding
F$1,510
16 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

5
MM
Murphy Scott MChief Accounting Officer
RPDRapid7, Inc.
Tax withholding
F$5,400
406 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$479K
11.5K sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$383K
9,258 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

4
RW
Ruttenberg David W.Director
ACELAccel Entertainment, Inc.
Open-market sale · 10b5-1 plan
SELL$145K
12.5K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$533K
13.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$348K
8,467 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$286K
7,046 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$448K
10.7K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

3
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Grant or award · 10b5-1 plan
A—
37.2K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

3
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M—
2,813 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

2
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$68K
14.6K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

2
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M$93K
5,893 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

1
PA
Peer AndrewVP, Corporate Controller & CAO
ACVAACV Auctions Inc.
Open-market sale · 10b5-1 plan
SELL$15K
1,750 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
PA
Peer AndrewVP, Corporate Controller & CAO
ACVAACV Auctions Inc.
Option exercise · 10b5-1 plan
M$4,270
1,750 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
250.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
62.5K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
IR
Inukonda RaviCHIEF FINANCIAL OFFICER
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M$7,790
1,017 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
GD
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
BDXBECTON DICKINSON & CO
Option exercise · 10b5-1 plan
M—
3,054 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence